qwertyuiopasdfghjklzxcvbnmqwerty

uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
th
11 Sep 2017
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
 11th Sep 2017

NIFTY

NIFTY FUT : R1:9975 R2:10010 R3:10055

PIVOT : 9943 S1:9921 S2:9892 S3:9864

NIFTY INTRADAY CHART

NIFTY OUTLOOK
Nifty is likely to open with a gap up opening. Momentum indicators are indicating towards bullish rule ahead.
Positional traders are advised to keep their stop loss at 9900 for their longs while for contra it should be placed
at 10,029.Intraday traders are advised to adopt buy on dips strategy for the day.

Strategy: long nifty around 9970 tgt 10000 sl 9935

Name Current Value Change % Chg Open High Low

FTSE 100 (Sep 8) 7,377.60 -19.38 -0.26 7,396.98 7,396.98 7,358.42

CAC 40 (Sep 8) 5,113.49 -1.13 -0.02 5,099.31 5,117.89 5,086.51
DAX (Sep 8) 12,303.98 7.35 0.06 12,261.81 12,321.61 12,245.33
Nikkei 225 (Sep
11) 19,555.32 280.5 1.43 19,441.39 19,567.03 19,437.14
Straits Times (Sep
11) 3,234.76 6.2 0.19 3,239.29 3,240.90 3,232.49
Hang Seng (Sep
11) 27,934.68 266.21 0.95 27,877.69 27,976.98 27,859.00

Taiwan Weighted
(Sep 11) 10,577.19 -32.76 -0.31 10,630.16 10,656.25 10,569.52

SGX Nifty (Sep 11) 10,013.00 66 0.66 9,942.00 10,018.50 9,933.50

WWW.EQUITYRESEARCHLAB.COM
 11th Sep 2017

CORPORATE NEWS

-Aurobindo Pharma gets US FDA nod for pelvic inflammation drug Metronidazole tablet
-Deep Industries has received letter of award (LOA) from ONGC for Ankleshwar asset extension
worth Rs 2.6 crore
-Oriental Bank of Commerce cuts one-year MCLR to 8.40 percent
-Lanco Infra has decided to exit its real estate investment to refocus on its core business
-Coal India to initiate long term supply contracts to supply 40mn tonnes under the Shakti scheme
-Wind developers upset over Karantaka tariff order that reduces the feed in tariff for discoms from Rs
4.5 per KWH to 3.74 per KWH
-Bharti Airtel, Idea Cellular in focus- Department of Telecommunications makes telecom gear testing
must from October 2018
-Commodity futures - SEBI mulls lifting decade old ban on tur, urad futures
-Tata Sons to reduce cross-holdings in Tata Chemicals, Tata Power: BS
-CRPL board may meet this week to take a call on 169 McDonalds stores: BS
-IndiGo (part of InterGlobe Aviation) eyes on wet lease to cash in on winter traffic: BS
-Airtel in talks with handset firms for Rs 2500 4G smartphone: BS
-Zee Entertainment eyes HD English movies with &Prive: ET
-Future Group looking to buyout Hypercity: ET
-Century Textiles may explore merger with Grasim after sale of paper division: BloombergQuint
-Shapoorji Pallonji, SSG Capital plan joint bid for Jyoti Structures acquisition: Mint
-SEBI to reduce mutual funds scheme by half
-China to ban sale of fossil fuel run cars
-ONGC's gas production plan from KG basin may miss June 2019 deadline: Mint
-Pitti Laminations gets shareholder nod to reappoint Sharad B Pitti as chairman & MD
-SC declines bail for Unitech MD Sanjay Chandra for not delivering flats: CNN-News18
-Idea says as directed by NCLT, shareholders, creditors to meet to consider amalgamation among
Vodaafone Mobile Services, Vodafone India & Company on October 12-Telecom Commission
sources say Rs 3,100 crore from USOF Fund will be used to set up about 4100 towers for uncovered
villages; contract has gone to Bharti Airtel

WWW.EQUITYRESEARCHLAB.COM
 11th Sep 2017

ERL RESEARCH TEAM

Member Name Designation

Mr. Tuhinanshu Jain Research Head
Mr. Manish Bimal Sr. Research Analyst
Mr. Anand Sharma Research Analyst
Mr. Sumit Sahu Research Analyst

DISCLAIMER

The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.

Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.

Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.

ALL RIGHTS RESERVED.

WWW.EQUITYRESEARCHLAB.COM